VANCOUVER, Aug. 2, 2016 /CNW/ - Reliq Health Technologies
Inc. (OTCQB: RQHTF) (TSXV: RHT) ("Reliq" or the
"Company"), a technology company focused on developing
innovative mobile health (mHealth) and telemedicine solutions for
Community-Based Healthcare, is pleased to announce that it has been
accepted into the National Health Service (NHS) United Kingdom's (UK's) Test Beds program and
will begin piloting its virtual care technology with a London-area hospital in Q4 2016.
"We are very excited to be piloting Reliq's community care
platform in the UK. Our technology is strongly aligned with NHS
England's ongoing initiative to improve the management of long term
conditions in the community," said Dr. Lisa
Crossley, CEO of Reliq Health. "Our platform uses a high
tech, low touch approach to provide high quality healthcare in the
home, reducing exacerbations and disease-related complications,
decreasing healthcare costs and enhancing patient and family
satisfaction. We look forward to participating in the NHS Test Beds
program to demonstrate the value of Reliq Health's technology to
patients, caregivers and the health system in the UK."
The pilot will focus on two of the most common chronic
conditions in the UK, congestive heart failure (CHF) and diabetes.
Currently there are over 15 million people in England living with at least one long-term
health condition. In addition to the impact on people's lives,
long-term condition management accounts for half of all General
Practitioner appointments and 70% of hospital bed days in the UK.
Reliq Health's proprietary hardware and software supports patients
and their caregivers in the home, providing remote vitals
monitoring with alerts to clinicians as needed, audible reminders
to improve patient compliance with prescribed medication regimens
and lifestyle changes, tailored patient education and secure
communication with the entire care team.
ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Cautionary Statements Regarding Forward Looking
Information
Certain statements in this press release constitute
forward-looking statements, within the meaning of applicable
securities laws. All statements that are not historical facts,
including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking statements" involve
known and unknown risks and uncertainties that could cause actual
and future events to differ materially from those anticipated in
such statements.
Forward-looking statements include, but are not limited to,
statements with respect to commercial operations, including
technology development, anticipated revenues, projected size of
market, and other information that is based on forecasts of future
results, estimates of amounts not yet determinable and assumptions
of management.
Reliq Health Technologies Inc. (the "Company") does not
intend, and does not assume any obligation, to update these
forward-looking statements except as required by law. These
forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing
activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially
from those expressed or implied by such forward-looking
statements.
Reliq Health Technologies Inc.
#1128 - 789 West Pender Street
Vancouver, B.C., V6C 1H2
Phone: +1-778-707-6673
Fax: +1-604-608-3906
SOURCE Reliq Health Technologies Inc.